Clinical trial
Divalproex Sodium (Depakote) for Explosive Tempers in Adolescents and Adults
NCT00218114 · New York State Psychiatric Institute, Other · Completed
Key facts
| NCT number | NCT00218114 |
|---|---|
| Title | Divalproex Sodium (Depakote) for Explosive Tempers in Adolescents and Adults |
| Official title | Parallel Groups Study of Divalproex Sodium (Depakote) for Irritable, Explosive Adults & Adolescents |
| Lead sponsor | New York State Psychiatric Institute, Other |
| Collaborators | National Institute on Drug Abuse (NIDA) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Attention Deficit and Disruptive Behavior Disorders, Marijuana Abuse |
| Intervention type | Drug |
| Interventions | Divalproex Sodium, Placebo |
| Enrollment | 25 |
| Start date | Feb 1, 2000 |
| Primary completion | Feb 18, 2005 |
| Completion | Feb 18, 2005 |
| First posted | Sep 22, 2005 |
| Last update posted | Aug 10, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: